These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24384000)

  • 21. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M; Robeva R; Popivanov P
    Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased bone mineral density in premenopausal patients with systemic lupus erythematosus.
    Chen CJ; Yen JH; Tsai WC; Lin MB; Hsu SC; Tsai JJ; Lin HC; Lu SN; Liu GC; Lin SF; Liu HW
    Kaohsiung J Med Sci; 1996 Oct; 12(10):567-72. PubMed ID: 8918077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone mineral density and disease activity in untreated systemic lupus erythematosus patients].
    Zhang FZ; Su MH; Li P
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2331-4. PubMed ID: 23158562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy.
    Ishida T; Yuri H; Nakamura E; Isoda K; Wada Y; Kotani T; Takeuchi T
    Lupus; 2022 Jun; 31(7):848-854. PubMed ID: 35440212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Mok CC; Ying SK; Ma KM; Wong CK
    Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
    Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
    Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D insufficiency in a large female SLE cohort.
    Toloza SM; Cole DE; Gladman DD; Ibañez D; Urowitz MB
    Lupus; 2010 Jan; 19(1):13-9. PubMed ID: 19897520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
    de Jong DJ; Corstens FH; Mannaerts L; van Rossum LG; Naber AH
    Am J Gastroenterol; 2002 Aug; 97(8):2011-5. PubMed ID: 12190169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Mok CC; To CH; Ma KM
    Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
    Gordon CM; Grace E; Emans SJ; Feldman HA; Goodman E; Becker KA; Rosen CJ; Gundberg CM; LeBoff MS
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria.
    Jung JY; Choi ST; Park SH; Kwon SR; Kim HA; Kim SS; Kim SH; Suh CH
    Osteoporos Sarcopenia; 2020 Dec; 6(4):173-178. PubMed ID: 33426305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus.
    Carli L; Tani C; Spera V; Vagelli R; Vagnani S; Mazzantini M; Di Munno O; Mosca M
    Lupus Sci Med; 2016; 3(1):e000098. PubMed ID: 26848397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.